APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lubiprostone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lubiprostone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025179 pages

Choose your research edition.

Industry ResearchLubiprostone Industry Research Report 2026103 pages · $2,950 USDIndustry Growth & TrendsGlobal Lubiprostone Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Lubiprostone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lubiprostone Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Lubiprostone Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Lubiprostone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Lubiprostone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lubiprostone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lubiprostone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lubiprostone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lubiprostone include Takeda Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Lubiprostone market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lubiprostone and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lubiprostone revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Lubiprostone market size, projected growth trends, production technologies, key applications, and end-use industries.

Lubiprostone Segment by Company

Takeda Pharmaceuticals

Lubiprostone Segment by Type

8 mcg Capsules

24 mcg Capsules

Lubiprostone Segment by Application

CIC and OIC

IBS-C

Lubiprostone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lubiprostone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lubiprostone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lubiprostone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Lubiprostone in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lubiprostone industry.

Chapter 3: Detailed analysis of Lubiprostone companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lubiprostonerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lubiprostone Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 8 mcg Capsules Table 3. Key Players of 24 mcg Capsules Table 4. Global Lubiprostone Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of CIC and OIC Table 6. Key Players of IBS-C Table 7. Global Lubiprostone Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Lubiprostone Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Lubiprostone Market Share by Region (2021-2026) Table 10. Global Lubiprostone Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Lubiprostone Market Share by Region (2027-2032) Table 12. Lubiprostone Industry Trends Table 13. Lubiprostone Industry Drivers Table 14. Lubiprostone Industry Opportunities and Challenges Table 15. Lubiprostone Industry Restraints Table 16. Global Lubiprostone Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Lubiprostone Revenue Market Share by Company (2021-2026) Table 18. Global Lubiprostone Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Lubiprostone Key Company Head Office and Area Served Table 20. Global Lubiprostone Company, Product Type & Application Table 21. Global Lubiprostone Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Lubiprostone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Lubiprostone Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lubiprostone Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Lubiprostone Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Lubiprostone Revenue Market Share by Type (2021-2026) Table 28. Global Lubiprostone Revenue Market Share by Type (2027-2032) Table 29. Global Lubiprostone Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lubiprostone Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Lubiprostone Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Lubiprostone Revenue Market Share by Application (2021-2026) Table 33. Global Lubiprostone Revenue Market Share by Application (2027-2032) Table 34. Takeda Pharmaceuticals Company Information Table 35. Takeda Pharmaceuticals Business Overview Table 36. Takeda Pharmaceuticals Lubiprostone Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Takeda Pharmaceuticals Lubiprostone Product Portfolio Table 38. Takeda Pharmaceuticals Recent Development Table 39. North America Lubiprostone Market Size by Type (2021-2026) & (US$ Million) Table 40. North America Lubiprostone Market Size by Type (2027-2032) & (US$ Million) Table 41. North America Lubiprostone Market Size by Application (2021-2026) & (US$ Million) Table 42. North America Lubiprostone Market Size by Application (2027-2032) & (US$ Million) Table 43. North America Lubiprostone Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 44. North America Lubiprostone Market Size by Country (2021-2026) Table 45. North America Lubiprostone Market Size by Country (2027-2032) Table 46. Europe Lubiprostone Market Size by Type (2021-2026) & (US$ Million) Table 47. Europe Lubiprostone Market Size by Type (2027-2032) & (US$ Million) Table 48. Europe Lubiprostone Market Size by Application (2021-2026) & (US$ Million) Table 49. Europe Lubiprostone Market Size by Application (2027-2032) & (US$ Million) Table 50. Europe Lubiprostone Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Europe Lubiprostone Market Size by Country (2021-2026) Table 52. Europe Lubiprostone Market Size by Country (2027-2032) Table 53. China Lubiprostone Market Size by Type (2021-2026) & (US$ Million) Table 54. China Lubiprostone Market Size by Type (2027-2032) & (US$ Million) Table 55. China Lubiprostone Market Size by Application (2021-2026) & (US$ Million) Table 56. China Lubiprostone Market Size by Application (2027-2032) & (US$ Million) Table 57. Asia Lubiprostone Market Size by Type (2021-2026) & (US$ Million) Table 58. Asia Lubiprostone Market Size by Type (2027-2032) & (US$ Million) Table 59. Asia Lubiprostone Market Size by Application (2021-2026) & (US$ Million) Table 60. Asia Lubiprostone Market Size by Application (2027-2032) & (US$ Million) Table 61. Asia Lubiprostone Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 62. Asia Lubiprostone Market Size by Country (2021-2026) Table 63. Asia Lubiprostone Market Size by Country (2027-2032) Table 64. South America, Middle East & Africa Lubiprostone Market Size by Type (2021-2026) & (US$ Million) Table 65. South America, Middle East & Africa Lubiprostone Market Size by Type (2027-2032) & (US$ Million) Table 66. South America, Middle East & Africa Lubiprostone Market Size by Application (2021-2026) & (US$ Million) Table 67. South America, Middle East & Africa Lubiprostone Market Size by Application (2027-2032) & (US$ Million) Table 68. South America, Middle East & Africa Lubiprostone Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 69. South America, Middle East & Africa Lubiprostone Market Size by Country (2021-2026) Table 70. South America, Middle East & Africa Lubiprostone Market Size by Country (2027-2032) Table 71. Research Programs/Design for This Report Table 72. Authors List of This Report Table 73. Secondary Sources Table 74. Primary Sources List of Figures Figure 1. Lubiprostone Product Image Figure 2. Global Lubiprostone Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Lubiprostone Market Share by Type: 2025 VS 2032 Figure 4. 8 mcg Capsules Image Figure 5. 24 mcg Capsules Image Figure 6. Global Lubiprostone Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Lubiprostone Market Share by Application: 2025 VS 2032 Figure 8. CIC and OIC Image Figure 9. IBS-C Image Figure 10. Global Lubiprostone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 12. Global Lubiprostone Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Lubiprostone Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Lubiprostone Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Lubiprostone Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Lubiprostone Revenue Market Share by Type (2021-2032) Figure 19. Global Lubiprostone Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Lubiprostone Revenue Market Share by Application (2021-2032) Figure 21. North America Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 22. North America Lubiprostone Market Share by Type (2021-2032) Figure 23. North America Lubiprostone Market Share by Application (2021-2032) Figure 24. North America Lubiprostone Market Share by Country (2021-2032) Figure 25. United States Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 26. Canada Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 28. Europe Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 29. Europe Lubiprostone Market Share by Type (2021-2032) Figure 30. Europe Lubiprostone Market Share by Application (2021-2032) Figure 31. Europe Lubiprostone Market Share by Country (2021-2032) Figure 32. Germany Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 33. France Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 35. Italy Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 36. Russia Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 38. China Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 39. China Lubiprostone Market Share by Type (2021-2032) Figure 40. China Lubiprostone Market Share by Application (2021-2032) Figure 41. Asia Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 42. Asia Lubiprostone Market Share by Type (2021-2032) Figure 43. Asia Lubiprostone Market Share by Application (2021-2032) Figure 44. Asia Lubiprostone Market Share by Country (2021-2032) Figure 45. Japan Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 49. India Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 50. Australia Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Lubiprostone Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Lubiprostone Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Lubiprostone Market Share by Country (2021-2032) Figure 55. Brazil Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 60. UAE Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 62. Chile Lubiprostone Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • 8 mcg Capsules
  • 24 mcg Capsules
Applications
  • CIC and OIC
  • IBS-C
Companies covered
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Lubiprostone Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 8 mcg Capsules
  5. 1.2.3 24 mcg Capsules
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Lubiprostone Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 CIC and OIC
  9. 1.3.3 IBS-C
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Lubiprostone Growth Trends by Region
  12. 1.5.1 Global Lubiprostone Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Lubiprostone Market Size by Region (2021-2026)
  14. 1.5.3 Lubiprostone Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Lubiprostone Market Dynamics
  1. 2.1 Lubiprostone Industry Trends
  2. 2.2 Lubiprostone Industry Drivers
  3. 2.3 Lubiprostone Industry Opportunities and Challenges
  4. 2.4 Lubiprostone Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Lubiprostone Revenue by Company (2021-2026)
  2. 3.2 Global Lubiprostone Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Lubiprostone Key Company Head office and Area Served
  4. 3.4 Global Lubiprostone Company, Product Type & Application
  5. 3.5 Global Lubiprostone Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Lubiprostone Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Lubiprostone Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Lubiprostone Tier 1, Tier 2, and Tier 3
4 Lubiprostone Market by Type
  1. 4.1 Global Lubiprostone Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Lubiprostone Market Size by Type (2021-2032)
  3. 4.3 Global Lubiprostone Market Size Share by Type (2021-2032)
5 Lubiprostone Market by Application
  1. 5.1 Global Lubiprostone Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Lubiprostone Market Size by Application (2021-2032)
  3. 5.3 Global Lubiprostone Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Takeda Pharmaceuticals
  2. 6.1.1 Takeda Pharmaceuticals Company Information
  3. 6.1.2 Takeda Pharmaceuticals Business Overview
  4. 6.1.3 Takeda Pharmaceuticals Lubiprostone Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Takeda Pharmaceuticals Lubiprostone Product Portfolio
  6. 6.1.5 Takeda Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Lubiprostone Market Size (2021-2032)
  2. 7.2 North America Lubiprostone Market Size by Type
  3. 7.2.1 North America Lubiprostone Market Size by Type (2021-2026)
  4. 7.2.2 North America Lubiprostone Market Size by Type (2027-2032)
  5. 7.2.3 North America Lubiprostone Market Share by Type (2021-2032)
  6. 7.3 North America Lubiprostone Market Size by Application
  7. 7.3.1 North America Lubiprostone Market Size by Application (2021-2026)
  8. 7.3.2 North America Lubiprostone Market Size by Application (2027-2032)
  9. 7.3.3 North America Lubiprostone Market Share by Application (2021-2032)
  10. 7.4 North America Lubiprostone Market Size by Country
  11. 7.4.1 North America Lubiprostone Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Lubiprostone Market Size by Country (2021-2026)
  13. 7.4.3 North America Lubiprostone Market Size by Country (2027-2032)
  14. 7.4.4 North America Lubiprostone Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Lubiprostone Market Size (2021-2032)
  2. 8.2 Europe Lubiprostone Market Size by Type
  3. 8.2.1 Europe Lubiprostone Market Size by Type (2021-2026)
  4. 8.2.2 Europe Lubiprostone Market Size by Type (2027-2032)
  5. 8.2.3 Europe Lubiprostone Market Share by Type (2021-2032)
  6. 8.3 Europe Lubiprostone Market Size by Application
  7. 8.3.1 Europe Lubiprostone Market Size by Application (2021-2026)
  8. 8.3.2 Europe Lubiprostone Market Size by Application (2027-2032)
  9. 8.3.3 Europe Lubiprostone Market Share by Application (2021-2032)
  10. 8.4 Europe Lubiprostone Market Size by Country
  11. 8.4.1 Europe Lubiprostone Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Lubiprostone Market Size by Country (2021-2026)
  13. 8.4.3 Europe Lubiprostone Market Size by Country (2027-2032)
  14. 8.4.4 Europe Lubiprostone Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Lubiprostone Market Size (2021-2032)
  2. 9.2 China Lubiprostone Market Size by Type
  3. 9.2.1 China Lubiprostone Market Size by Type (2021-2026)
  4. 9.2.2 China Lubiprostone Market Size by Type (2027-2032)
  5. 9.2.3 China Lubiprostone Market Share by Type (2021-2032)
  6. 9.3 China Lubiprostone Market Size by Application
  7. 9.3.1 China Lubiprostone Market Size by Application (2021-2026)
  8. 9.3.2 China Lubiprostone Market Size by Application (2027-2032)
  9. 9.3.3 China Lubiprostone Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Lubiprostone Market Size (2021-2032)
  2. 10.2 Asia Lubiprostone Market Size by Type
  3. 10.2.1 Asia Lubiprostone Market Size by Type (2021-2026)
  4. 10.2.2 Asia Lubiprostone Market Size by Type (2027-2032)
  5. 10.2.3 Asia Lubiprostone Market Share by Type (2021-2032)
  6. 10.3 Asia Lubiprostone Market Size by Application
  7. 10.3.1 Asia Lubiprostone Market Size by Application (2021-2026)
  8. 10.3.2 Asia Lubiprostone Market Size by Application (2027-2032)
  9. 10.3.3 Asia Lubiprostone Market Share by Application (2021-2032)
  10. 10.4 Asia Lubiprostone Market Size by Country
  11. 10.4.1 Asia Lubiprostone Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Lubiprostone Market Size by Country (2021-2026)
  13. 10.4.3 Asia Lubiprostone Market Size by Country (2027-2032)
  14. 10.4.4 Asia Lubiprostone Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Lubiprostone Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Lubiprostone Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Lubiprostone Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Lubiprostone Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Lubiprostone Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Lubiprostone Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Lubiprostone Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Lubiprostone Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Lubiprostone Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Lubiprostone Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Lubiprostone Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Lubiprostone Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Lubiprostone Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Lubiprostone Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst